Fingerprint
Dive into the research topics of 'Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
Neelesh Sharma, Nathan Pennell, Myles Nickolich, Balazs Halmos, Patrick Ma, Tarek Mekhail, Pingfu Fu, Afshin Dowlati
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations